IL18 and Alzheimer disease: Another study showed that PBMCs from patients with AD have a decreased IL-18 expression and capacity to produce IFN-γ, which is inversely correlated with serum IgE concentrations (Higashi et al., 2001), suggesting an IL-18 role in the skewing of the immune system in patients with AD.